Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT00206193
Other study ID # TOP-protocol
Secondary ID
Status Recruiting
Phase Phase 2
First received September 13, 2005
Last updated October 29, 2007

Study information

Verified date September 2005
Source Atrium Medical Center
Contact Suzanne HW Vonken, Dr.
Phone 003145-5766666
Email svonken@gmail.com
Is FDA regulated No
Health authority United States: Food and Drug Administration
Study type Observational

Clinical Trial Summary

The purpose of this study is to determine which medical treatment is the most effective to terminate a pregnancy.


Recruitment information / eligibility

Status Recruiting
Enrollment 0
Est. completion date
Est. primary completion date
Accepts healthy volunteers
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Pregnant women by whom a termination of pregnancy is desired.

Exclusion Criteria:

- Women with liver/kidney disease

- Women on long-term use of corticosteroids (> 6 months)

- Cardiovascular problems

- Therapy-resistant diabetic women

- Therapy-resistant asthma/bronchitis

- Thalassemia

- Ulcerative colitis

- Peptic ulcer disease

- Glaucoma

- Porphyria

- Allergic reaction to prostaglandin or mifepristone

- Women with a prior caesarian section or women with contractions at the start of the study

Study Design

Time Perspective: Prospective


Related Conditions & MeSH terms


Intervention

Drug:
mifepristone

misoprostol

sulprostone


Locations

Country Name City State
Netherlands Atrium Medisch Centrum Heerlen Limburg

Sponsors (1)

Lead Sponsor Collaborator
Atrium Medical Center

Country where clinical trial is conducted

Netherlands, 

See also
  Status Clinical Trial Phase
Completed NCT01541293 - Intrauterine Lidocaine for Laminaria Phase 1
Completed NCT00177333 - Serum Levels of Doxycycline at the Time of Abortion With Two Dosing Regimens Phase 4
Completed NCT00370487 - Comparison of the Safety of First Trimester Abortions Performed by Physicians and Non-Physicians in South Africa and Viet Nam. N/A
Completed NCT00188071 - Postoperative Pain After Medical Abortion Under Local Anesthesia : Comparison of Several Analgesic Regimen N/A
Completed NCT02277249 - Transvaginal Versus Transabdominal Digoxin Prior to Second-trimester Abortion N/A
Completed NCT00386867 - A Randomized Trial of Buccal Compared to Oral Misoprostol Following Mifepristone for Medical Abortion up to 63 Days LMP N/A
Completed NCT00677755 - Medical Abortion for Emergency Contraception Failure N/A
Completed NCT02279914 - Misoprostol Dose and Timing Before Surgical Abortion at 13 to 16 Weeks' Gestation: a Randomized Trial N/A
Completed NCT01615731 - Value of Mifepristone in Cervical Preparation Prior to Dilation and Evacuation 19-24 Weeks N/A
Completed NCT01597726 - Cervical Priming Before Dilation & Evacuation N/A
Completed NCT02318212 - Dilapan-S / Dilasoft E-Registry in Induced Abortion N/A
Terminated NCT00855842 - Pilot Study of the Addition of Osmotic Dilators to Preparation Prior to Labor Induction Abortion N/A
Completed NCT00330993 - Oral Mifepristone and Buccal Misoprostol Administered Simultaneously for Abortion Through 63 Days Gestation Phase 2
Completed NCT00382538 - Mifepristone and Mid-Trimester Termination of Pregnancy N/A
Completed NCT03080493 - Gabapentin for Pain Control After Osmotic Dilator Insertion and Prior to D&E Procedure: a Randomized Controlled Trial Phase 4
Completed NCT02485444 - Oxytocin Infusion vs. Spontaneous Follow-up for Third-stage of Labor After Second-trimester Abortion Phase 4
Completed NCT00969982 - Mifepristone Plus Misoprostol Versus Misoprostol Alone for 2nd Trimester Abortion (14 - 21 Weeks Last Menstrual Period (LMP)) N/A
Recruiting NCT02480543 - Different Routes of Misoprostol Prior to First Trimester Surgical Abortion Phase 4
Completed NCT00870272 - Study of 400mcg Sublingual Versus 400mcg Buccal Misoprostol Following 200mg Mifepristone for Medical Abortion up to 63 Days Last Menstrual Period (LMP) N/A
Completed NCT02048098 - Misoprostol for Second Trimester Termination of Pregnancy Phase 3